Skip to main content
    H

    HCW Biologics Inc (HCWB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.79
    +0.01 (+1.54%)

    Market Cap: $1.73M

    Last updated: Nov 17, 2026 at 10:58 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    33%(6/18)
    Avg Surprise
    -59.49%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$1.42
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-83.10%Operating Margin-92.00%
    ROE-151.40%ROIC-51.63%
    Financial Health
    Debt/Equity1.00xInterest Coverage1.67x
    Current Ratio0.07xQuick Ratio0.07x
    Trading Statistics
    Beta2.27Avg Volume50.09K
    52-Week High$23.9452-Week Low$0.76

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 47.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 23.4, below 30, the oversold line.

    Moving Averages

    SMA 10$0.94
    SMA 20$1.04
    SMA 50$1.48
    SMA 200$3.75
    EMA 10$0.91
    EMA 20$1.05
    EMA 50$1.58
    EMA 200$5.90

    MACD

    Line: -0.20Signal: -0.20Hist: 0.00

    ADX

    ADX: 14.9+DI: 14.9-DI: 30.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$1.05

    Bollinger Bands

    Upper Band$1.33
    Lower Band$0.76
    %B Position5470%(Upper)
    Band Width0.05

    RSI (14-Day)

    Oversold
    23.4

    Momentum Oscillators

    Stoch %K5.5
    Stoch %D3.6
    Williams %R-92.1
    ROC (10d)-29.9%
    Momentum-0.34
    CCI (20d)-158.0
    MFI (14d)24.8

    Volatility Measures

    ATR (14d)$0.12(15.5%)
    StdDev (20d)0.14
    Hist Vol69.5%(High)

    Volume Flow

    VWAP$0.79
    OBV1.2B
    AD Line40.3B
    CMF (20d)-0.412

    Volume Metrics

    Avg Vol (20d)47.6K
    Vol Ratio1.8x(High)
    VWMA (20d)$1.06

    Pivot Points

    R3$0.91
    R2$0.89
    R1$0.83
    Pivot Point$0.80
    S1$0.74
    S2$0.72
    S3$0.66

    Advanced Oscillators

    TSI-46.21
    Ultimate Osc18.0
    KST-336.21

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about HCWB

    News

    HCWB Valuation

    HCWB Profitability: Margins, ROIC and FCF

    HCW Biologics (HCWB) has a gross margin of 95.7%, an operating margin of -92.0% and a net margin of -83.1%. It posts -51.6% ROIC and a -170.4% FCF margin.

    Gross margin
    95.7%
    Operating margin
    -92.0%
    Net margin
    -83.1%
    ROIC
    -51.6%
    ROE
    -151.4%
    FCF margin
    -170.4%
    HCWB financial statements

    HCW Biologics Competitors

    The companies most similar to HCW Biologics (HCWB) include Calidi Biotherapeutics, Scinai Immunotherapeutics and Ernexa Therapeutics.

    Sector: Healthcare

    Companies most similar to HCW Biologics

    HCWB Bull Case vs Bear Case

    Bull case

    • HCWB grew quarterly revenue 1970.0% year over year.

    Bear case

    • HCWB has a -83.1% net profit margin.
    • HCWB beat EPS estimates in 25.0% of its last 8 reported quarters.

    HCWB Earnings: Beat Rate and Next Report

    HCW Biologics (HCWB) beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate (25.0%).

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -115.8%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$1.42
    HCWB earnings history

    Updated Nov 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About HCWB

    Does HCWB pay dividends?

    HCW Biologics Inc (HCWB) does not currently pay a regular dividend.

    What is HCWB's market cap?

    HCW Biologics Inc (HCWB) has a market capitalization of $1.73M with a current stock price of $0.79.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.